Target sequence-conditioned design of peptide binders using masked language modeling
Nature Biotechnology – PepMLM designs peptide binders against diverse targets using masked language modeling.
Related Articles
A personal health large language model for sleep and fitness coaching
Nature Medicine – A large language model designed for health monitoring provides personalized sleep and fitness predictions, insights and advice.
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers
Communications Medicine – Dörr, Lacy et al. evaluate the association between SARS-CoV-2 vaccination status and influenza-like illness and sick leave among 1745 Swiss healthcare workers.…
Youths buried in Anglo-Saxon cemeteries carried West African DNA
Despite bearing remarkably far-flung genetic origins, a girl and young man were buried just like their peers
Roxie Laybourne, the first forensic ornithologist
A new biography probes the life of a taxidermist turned avian investigator
Pancreatic Precancer Cells in Mice Reveal Autophagy Defects, Protein Clumps
Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer development insights.
NIH director orders new review of grants in outline of top research priorities
Many topics on Bhattacharya’s list are familiar, but order to re-evaluate grants draws concerns
The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cells
Single-cell imaging and information theory reveal key drivers of EMT heterogeneity in pancreatic cancer cells and tumors.
Insect X-Men: Helmets help these odd bugs sense electric fields
Ability may help treehoppers distinguish friend from foe
Whole-exome sequencing analysis identifies risk genes for schizophrenia
Nature Communications – Here the authors analyse rare coding variants to identify schizophrenia risk genes. Associations are reported at exome-wide significance for STAG1 and ZNF136,…
Metastatic Cancers Eliminated by CD40 Agnostic Antibody
Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.